Internal Medicine, Nephrology · Voorhees, NJ
NPI
1144277518
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
201 Laurel Oak Rd., Suite B
Voorhees, NJ, 08043
Phone (856) 566-5478
Groups this clinician bills Medicare through
Medicare paid, 2024
$291K
1,997 services
Medicare patients, 2024
506
Average age 74
Drug cost, 2024
$831K
2,595 prescriptions
Company payments, 2025
$1,726
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carmen L Canals Navas was code 90960 (esrd related services (not dialysis)), 585 times for 93 patients. In total Carmen L Canals Navas billed 1,997 services in 24 codes, and Medicare paid $291K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-01-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Office | 585 | 93 | $285.40 | $167K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 326 | 137 | $12.65 | $4,122 |
| 99214 Office E&M - Established | Office | 272 | 126 | $72.00 | $20K |
| 99232 Hospital E&M - Subsequent | Facility | 248 | 156 | $62.77 | $16K |
| 90961 ESRD Related Services (not dialysis) | Office | 119 | 62 | $234.93 | $28K |
| 99233 Hospital E&M - Subsequent | Facility | 76 | 59 | $97.29 | $7,394 |
| 99215 Office E&M - Established | Office | 71 | 45 | $90.00 | $6,390 |
| 99222 Hospital E&M - Initial | Facility | 53 | 51 | $104.42 | $5,534 |
| 99223 Hospital E&M - Initial | Facility | 47 | 46 | $141.97 | $6,673 |
| 90935 Hemodialysis | Facility | 33 | 29 | $56.13 | $1,852 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 28 | 24 | $226.92 | $6,354 |
| 99205 Office E&M - New | Office | 20 | 20 | $162.07 | $3,241 |
| 99213 Office E&M - Established | Office | 15 | 13 | $46.40 | $696 |
By year: 2022 $317K for 1,583 services; 2023 $308K for 1,789 services; 2024 $291K for 1,997 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carmen L Canals Navas prescribed most often to Medicare patients was Hydralazine Hcl, with 215 prescriptions and refills. In total Carmen L Canals Navas wrote 2,595 Medicare prescriptions that cost $831K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydralazine Hcl Generic | 215 | 492 | 61 | $3,629 |
| Farxiga Dapagliflozin Propanediol | 193 | 308 | 38 | $169K |
| Furosemide Generic | 144 | 336 | 42 | $683 |
| Amlodipine Besylate Generic | 132 | 347 | 43 | $830 |
| Losartan Potassium Generic | 110 | 306 | 36 | $1,478 |
| Sevelamer Carbonate Generic | 107 | 230 | 43 | $20K |
| Allopurinol Generic | 103 | 285 | 32 | $971 |
| Atorvastatin Calcium Generic | 96 | 253 | 30 | $927 |
| Metoprolol Succinate Generic | 68 | 204 | 21 | $1,289 |
| Carvedilol Generic | 65 | 186 | 26 | $582 |
| Nifedipine Er Nifedipine | 51 | 77 | Under 11 | $1,239 |
| Lanthanum Carbonate Generic | 49 | 71 | 13 | $61K |
| Lisinopril Generic | 44 | 118 | 16 | $490 |
| Kerendia Finerenone | 43 | 65 | Under 11 | $40K |
| Doxazosin Mesylate Generic | 43 | 95 | 13 | $639 |
Brand drugs: - claims; generic drugs: 2,063 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carmen L Canals Navas $1,726 ($1,726 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $356.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 15 | $356 |
| Fresenius USA Marketing, Inc. | 14 | $222 |
| Calliditas Therapeutics US Inc. | 5 | $176 |
| ANI Pharmaceuticals, Inc. ANIP | 8 | $148 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $95.55 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $80.07 |
| Genzyme Corporation SNY | 2 | $70.3 |
| Travere Therapeutics, Inc. TVTX | 7 | $69.72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $64.12 |
| Ardelyx, Inc. ARDX | 3 | $60.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.